Summary
This large-scale genomic study published in Nature Genetics examined the genetic architecture underlying 35 commonly measured blood and urine biomarkers in over 400,000 UK Biobank participants. The authors conducted comprehensive GWAS analyses to identify genetic variants associated with these clinical measures, characterising heritability and genetic correlations across biomarkers. The work provides a foundational reference for understanding the heritable component of metabolic and clinical traits relevant to human health outcomes.
UK applicability
As the study was conducted entirely within the UK Biobank population, findings are directly applicable to understanding genetic variation in biomarker levels amongst UK populations. Results may inform UK clinical genetics research and the interpretation of biomarker variation in precision medicine contexts.
Key measures
Genome-wide association statistics for 35 blood and urine biomarkers; heritability estimates; genetic correlation matrices; variant effect sizes and frequencies
Outcomes reported
The study identified genetic variants associated with 35 blood and urine biomarkers using genome-wide association study (GWAS) methodology in the UK Biobank cohort. The research characterised the heritability and genetic architecture of these clinical and metabolic biomarkers.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.